Tamarkin Pharmaceutical Innovation Ltd. (TPI)

Tamarkin Pharmaceutical Innovation (TPI) is a biopharmaceutical company, developing proprietary therapeutic agents in the field of dermatology. The company has developed a novel family of Dual Action Pro-drugs (DAPDRUGs), which are programmed to penetrate the skin and provide it with a plurality of therapeutic effects. The Companies lead product, TU-2100 is currently in the advanced stage of Phase II clinical studies, while other molecules are still in earlier stages of development. TPI also develops certain cosmetic products, which will be launched in Israel and worldwide during 2000-2001. TPI is actively seeking alliances with leading pharmaceutical companies.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Cosmoceuticals
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: